Lifeboat Foundation

Year 2020 face_with_colon_three

There’s a new disease-detecting technology in the lab of Sanjiv “Sam” Gambhir, MD PhD, and its No. 1 source of data is number one. And number two.

Continue reading “‘Smart toilet’ monitors for signs of disease” »

Summary: Researchers developed an innovated a technique to convert complex neuroimaging data into audiovisual formats. By transforming brain activity and blood flow data from behaviors like running or grooming in mice into synchronized piano and violin sounds, accompanied by video, they offer an intuitive approach to explore the brain’s intricate workings.

This method not only makes it easier to identify patterns in large datasets but also enhances the understanding of the dynamic relationship between neuronal activity and behavior. The toolkit represents a significant step forward in neuroscientific research, enabling scientists to intuitively screen and interpret vast amounts of brain data.

Inspired by photovoltaic cells, the technology could also be used for neuromodulation and treating diseases like Parkinson’s.

Using two layers of P-type silicon, researchers made an ultra thin membrane that converts light into electric charges to adjust the heart’s beat.

The team found that administering an HDAC inhibitor orally effectively halted sperm production and fertility in mice while preserving the sex drive.

Researchers are grappling with the challenge of developing effective male contraceptives as existing attempts to block sperm production, maturation, or fertilization have fallen short, either offering incomplete protection or leading to severe side effects.

Now, a team of researchers at the Salk Institute in the US has developed a novel approach to halting sperm production, which is both non-hormonal and reversible, marking a significant advancement in male contraception research.

Continue reading “Scientists unlock key to reversible, non-hormonal male birth control” »

This study reveals a mechanism by which the environment, diet in this case, can influence cancer risk.

Imagine an army of self-propelling, radioisotope-covered particles 2,500 to 10,000 times smaller than a speck of dust that, upon injection into the body, search for and attach themselves to cancerous tumours, destroying them. Sounds like science fiction? Not so for mice with bladder cancer.

Researchers in Spain report that nanoparticles containing radioactive iodine and which propel themselves upon reaction with urea have the ability to distinguish cancerous bladder tumours from healthy tissue. These “nanobots” penetrate the tumour’s extracellular matrix and accumulate within it, enabling the radionuclide therapy to reach its precise target. In a study conducted at the Institute for Bioengineering of Catalonia (IBEC) in Barcelona, mice receiving a single dose of this treatment had a 90% reduction in the size of bladder tumours compared with untreated animals.

This novel approach may one day revolutionize the treatment of bladder cancer. Bladder cancer is the tenth most common cancer in the world, with over 600,000 new cases diagnosed in 2022 and more than 220,000 deaths globally, according to the World Health Organization’s Global Cancer Observatory.

“Megaworkup” revealed brain and immune differences in a small patient group.

Study shows power of paleogenomics to explore incidence of disability in the past.

Australian researchers have worked out how to fix a defect that causes lupus, and hope their world-first discovery will offer effective long-term treatment.

Published in Nature Communications, the Monash University-led study found a way to reprogram the defective cells of lupus patients with protective molecules from healthy people.

Using human cells, the new treatment restores the protective side of the immune system that prevents autoimmunity, which is when the immune system attacks its own cells.